跳至主要内容
临床试验/KCT0004028
KCT0004028已完成未知

The multi-center clinical trial on the recurrence prevention and safety by injection of Meditoxin® (Botulinum toxin) in chronic sialoadenitis patients

Bundang CHA General Hospital0 个研究点目标入组 14 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
14

研究概览

简要总结

All subjective symptoms decreased significantly until 1 month and then increased. However, at 6 months, all subjective symptoms were determined to be better than before injection. The unstimulated and stimulated salivary flow rate did not show a significant difference over time. No significant difference was noted in parotid gland volume or uptake on salivary SPECT–CT over time.

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20?(Year) 至 70?(Year)(—)
性别
All

入选标准

  • The enrolled patient should comply with all of the following criteria.
  • 1) Men and women over 20 and under 70
  • 2) The patient who have experienced symptoms for more than 6 months
  • 3) The patient who repeat 3 or more episodes of sialoadenitis
  • 4) The patient who voluntarily decided to participate and signed the consent form before starting this clinical trial

排除标准

  • Patients who fall under any of the following criteria are not allowed to register for this clinical trial.
  • 1) Patients who have been confirmed to have a stone or tumor in the salivary gland by CT or MRI
  • 2) Patients with salivary glands hypertrophy without pain or pressure sense
  • 3) Patients who participated in other clinical trials within last 1 month
  • 4) Patients with less than a longer period of five times the half-life of medicines in previous clinical trials
  • 5) Patient who have the contraindication of Meditoxin
  • 6) In addition to the above, patients who are deemed inappropriate for this trial by investigator

研究者

发起方
Bundang CHA General Hospital

相似试验